Akili Inc Stock Price To Sales
Akili Inc fundamentals help investors to digest information that contributes to Akili's financial success or failures. It also enables traders to predict the movement of Akili Stock. The fundamental analysis module provides a way to measure Akili's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Akili stock.
Akili |
Akili Inc Company Price To Sales Analysis
Akili's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Akili Price To Sales | 12.31 X |
Most of Akili's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Akili Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
CompetitionBased on the latest financial disclosure, Akili Inc has a Price To Sales of 12.314 times. This is 42.46% lower than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The price to sales for all United States stocks is 7.83% lower than that of the firm.
Akili Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Akili's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Akili could also be used in its relative valuation, which is a method of valuing Akili by comparing valuation metrics of similar companies.Akili is currently under evaluation in price to sales category among its peers.
Akili Fundamentals
| Return On Equity | -0.68 | |||
| Return On Asset | -0.37 | |||
| Operating Margin | (28.37) % | |||
| Current Valuation | (15.56 M) | |||
| Shares Outstanding | 78.73 M | |||
| Shares Owned By Insiders | 23.21 % | |||
| Shares Owned By Institutions | 61.47 % | |||
| Number Of Shares Shorted | 271.35 K | |||
| Price To Book | 0.35 X | |||
| Price To Sales | 12.31 X | |||
| Revenue | 1.68 M | |||
| Gross Profit | (118 K) | |||
| EBITDA | (60.14 M) | |||
| Net Income | (59.49 M) | |||
| Cash And Equivalents | 45.62 M | |||
| Cash Per Share | 0.53 X | |||
| Total Debt | 15.48 M | |||
| Debt To Equity | 0.79 % | |||
| Current Ratio | 4.78 X | |||
| Book Value Per Share | 0.64 X | |||
| Cash Flow From Operations | (57.87 M) | |||
| Short Ratio | 0.31 X | |||
| Earnings Per Share | (0.61) X | |||
| Target Price | 0.65 | |||
| Number Of Employees | 68 | |||
| Beta | 1.73 | |||
| Market Capitalization | 34.1 M | |||
| Total Asset | 80.38 M | |||
| Retained Earnings | (299.78 M) | |||
| Working Capital | 65.06 M | |||
| Net Asset | 80.38 M |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Consideration for investing in Akili Stock
If you are still planning to invest in Akili Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Akili's history and understand the potential risks before investing.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |